Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer

Clinical trial NCT04721132 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04721132
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Hepatocellular Carcinoma Stage I Hepatocellular Carcinoma AJCC v8 Stage IA Hepatocellular Carcinoma AJCC v8 Stage IB Hepatocellular Carcinoma AJCC v8 Stage II Hepatocellular Carcinoma AJCC v8

Start date: 2021-02-10
Primary completion: 2027-05-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.